Baudax Bio shares trading higher after the company agreed to acquire TeraImmune in a stock-for-stock transaction.
Portfolio Pulse from Benzinga Newsdesk
Baudax Bio has agreed to acquire TeraImmune in a stock-for-stock transaction, leading to a rise in Baudax Bio's share price.
June 30, 2023 | 1:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Baudax Bio's acquisition of TeraImmune has led to an increase in its share price.
The acquisition of TeraImmune by Baudax Bio is a significant event for the company, which has led to an increase in its share price. This suggests that the market views this acquisition positively, which could lead to further increases in the share price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100